Global Nucleic Acid Amplification Testing (NAAT) Market to reach USD 5.5 billion by 2027.

Global Nucleic Acid Amplification Testing (NAAT) Market Size study, by Technique (Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems), by Application (Infectious Disease, Cancer, Others) and Regional Forecasts 2020-2027
Product Code:  HALMD_59511566
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Nucleic Acid Amplification Testing (NAAT) Market, by Region, 2018-2027 (USD Billion)
1.2.2.	Nucleic Acid Amplification Testing (NAAT) Market, by Technique, 2018-2027 (USD Billion)
1.2.3.	Nucleic Acid Amplification Testing (NAAT) Market, by Application, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Nucleic Acid Amplification Testing (NAAT) Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Nucleic Acid Amplification Testing (NAAT) Market Dynamics	
3.1.	Nucleic Acid Amplification Testing (NAAT) Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Nucleic Acid Amplification Testing (NAAT) Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Nucleic Acid Amplification Testing (NAAT) Market, by Technique 
5.1.	Market Snapshot 
5.2.	Global Nucleic Acid Amplification Testing (NAAT) Market by Technique, Performance - Potential Analysis
5.3.	Global Nucleic Acid Amplification Testing (NAAT) Market Estimates & Forecasts by Technique 2017-2027 (USD Billion)
5.4.	Nucleic Acid Amplification Testing (NAAT) Market, Sub Segment Analysis
5.4.1.	Target Amplification Systems
5.4.2.	Probe Amplification Systems
5.4.3.	Signal Amplification Systems
Chapter 6.	Global Nucleic Acid Amplification Testing (NAAT) Market, by Application          
6.1.	Market Snapshot 
6.2.	Global Nucleic Acid Amplification Testing (NAAT) Market by Application, Performance - Potential Analysis
6.3.	Global Nucleic Acid Amplification Testing (NAAT) Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4.	Nucleic Acid Amplification Testing (NAAT) Market, Sub Segment Analysis
6.4.1.	Infectious Disease
6.4.2.	Cancer
6.4.3.	Others
Chapter 7.	Global Nucleic Acid Amplification Testing (NAAT) Market, Regional Analysis
7.1.	Nucleic Acid Amplification Testing (NAAT) Market, Regional Market Snapshot 
7.2.	North America Nucleic Acid Amplification Testing (NAAT) Market 
7.2.1.	U.S. Nucleic Acid Amplification Testing (NAAT) Market
7.2.1.1.	Technique breakdown estimates & forecasts, 2017-2027
7.2.1.2.	Application breakdown estimates & forecasts, 2017-2027
7.2.2.	Canada Nucleic Acid Amplification Testing (NAAT) Market
7.3.	Europe Nucleic Acid Amplification Testing (NAAT) Market Snapshot
7.3.1.	U.K. Nucleic Acid Amplification Testing (NAAT) Market 
7.3.2.	Germany Nucleic Acid Amplification Testing (NAAT) Market
7.3.3.	France Nucleic Acid Amplification Testing (NAAT) Market
7.3.4.	Spain Nucleic Acid Amplification Testing (NAAT) Market
7.3.5.	Italy Nucleic Acid Amplification Testing (NAAT) Market
7.3.6.	Rest of Europe Nucleic Acid Amplification Testing (NAAT) Market
7.4.	Asia-Pacific Nucleic Acid Amplification Testing (NAAT) Market Snapshot
7.4.1.	China Nucleic Acid Amplification Testing (NAAT) Market 
7.4.2.	India Nucleic Acid Amplification Testing (NAAT) Market 
7.4.3.	Japan Nucleic Acid Amplification Testing (NAAT) Market
7.4.4.	Australia Nucleic Acid Amplification Testing (NAAT) Market
7.4.5.	South Korea Nucleic Acid Amplification Testing (NAAT) Market
7.4.6.	Rest of Asia Pacific Nucleic Acid Amplification Testing (NAAT) Market
7.5.	Latin America Nucleic Acid Amplification Testing (NAAT) Market Snapshot
7.5.1.	Brazil Nucleic Acid Amplification Testing (NAAT) Market
7.5.2.	Mexico Nucleic Acid Amplification Testing (NAAT) Market
7.6.	Rest of The World Nucleic Acid Amplification Testing (NAAT) Market
Chapter 8.	Competitive Intelligence
8.1.	Top Market Strategies
8.2.	Company Profiles
8.2.1.	Abbott Laboratories
8.2.1.1.	Key Information
8.2.1.2.	Overview
8.2.1.3.	Financial (Subject to Data Availability)
8.2.1.4.	Product Summary
8.2.1.5.	Recent Developments
8.2.2.	Becton, Dickinson and Company
8.2.3.	BioMérieux S.A.
8.2.4.	Bio-Rad Laboratories, Inc.
8.2.5.	Grifols, S.A.
8.2.6.	F. Hoffmann-La Roche AG
8.2.7.	Hologic, Inc.
8.2.8.	Illumina, Inc.
8.2.9.	Beckman Coulter, Inc.
8.2.10.	Siemens Healthcare GmbH
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.2.	Research Attributes
9.3.	Research Assumption

Global Nucleic Acid Amplification Testing (NAAT) Market is valued at approximately USD 2.5 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.4% over the forecast period 2020-2027. Nucleic Acid Amplification Test (NAAT) is an innovative technique used for the identification of a specific nucleic acid, bacteria, or virus, that act as a disease-causing pathogen from biologic samples, such as urine, tissues. etc. Furthermore, this technique is often utilized for blood screening donations to mitigate the risk of transfusion-transmitted infections in the recipients. Besides, nucleic acid amplification test is the precise detection technique used for most of the infectious agents, as it helps diagnose and improve patients care in high-income countries. Thus, it is extensively adopted over conventional diagnostic techniques for treating and curing infectious diseases, such as HIV and Ebola. According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), in 2019, nearly 1.7 million individuals were newly affected by HIV , compared to a 2.8 million adult population in 1998. Thus, the rise in prevalence of HIV diseases throughout the world will foster the adoption for NAAT in the forthcoming period. Along with infectious diseases, NAAT is being extensively used across numerous other fields, including cancer, personalized medicine, and forensics. This is likely to spur the adoption & utility for NAAT during the forecast period. In addition, the rise in expenditure or investment in pharmaceutical and biopharmaceutical sector, along with escalating demand for the advanced diagnostic measure are the few factors responsible for the high CAGR of the market during the forecast period. For instance, the Association of the British Pharmaceutical Industry (ABPI) estimated that the biopharmaceutical companies worldwide spent around USD 156.7 billion on R&D activities in 2016, representing an increase from USD 148 billion in 2015. Further , it is likely to grow around USD 181 billion by the year 2022. This, in turn, is likely to strengthen the demand for nucleic acid amplification testing (NAAT), thereby contributing to the market growth around the world. However, the high cost of test and shortage of skilled professionals are the major factors restraining the market growth over the forecast period 2020-2027.

The regional analysis of the global Nucleic Acid Amplification Testing (NAAT) market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising government support to implement Nucleic Acid Amplification Testing (NAAT), along with the significant presence of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of life-threatening diseases and infectious diseases and rising adoption of innovative diagnostic technologies in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the Nucleic Acid Amplification Testing (NAAT) market in the Asia-Pacific region.

Major market player included in this report are:
Abbott Laboratories
Becton, Dickinson and Company
BioMérieux S.A.
Bio-Rad Laboratories, Inc.
Grifols, S.A.
F. Hoffmann-La Roche AG
Hologic, Inc.
Illumina, Inc.
Beckman Coulter, Inc.
Siemens Healthcare GmbH

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technique:
Target Amplification Systems
Probe Amplification Systems
Signal Amplification Systems

By Application:
Infectious Disease
Cancer
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Nucleic Acid Amplification Testing (NAAT) Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…